If conventional ADHD treatments have fallen short, medical cannabis for ADHD in the UK may be an option. LeafEase clinicians can assess your eligibility online.
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition characterised by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with daily functioning.
It affects both children and adults, with an estimated 2.5 million people in the UK currently living with the condition and over 549,000 waiting for a formal NHS assessment as of May 2025. ¹ Many adults are diagnosed later in life after years of unmanaged symptoms.
ADHD is a neurodevelopmental condition with no single identified cause. Research points to a combination of genetic, neurological, and environmental factors that affect how the brain develops and regulates attention and behaviour.
Studies suggest that differences in dopamine and norepinephrine signalling in the brain play a central role in ADHD symptoms.
Common contributing factors may include:
ADHD is not caused by poor parenting, diet, or screen time, though these factors may influence how symptoms present.
In the UK, ADHD is typically managed through a combination of stimulant medications such as methylphenidate or lisdexamfetamine, non-stimulant alternatives, and structured behavioural therapy. Many patients also benefit from psychoeducation and workplace or academic support adjustments.
For individuals whose symptoms remain difficult to control through standard treatments, medical cannabis for ADHD may offer an alternative pathway under specialist supervision. At LeafEase, patients can access a comprehensive care approach designed to assess eligibility and support safe, effective symptom management throughout their treatment journey.
Yes. Medical cannabis for ADHD in the UK can be legally prescribed through a specialist private clinic when conventional treatments have not worked or have caused intolerable side effects.
Medical cannabis has been legal to prescribe in the UK since November 2018. ² It is not available on the NHS for ADHD but can be accessed through CQC-regulated clinics like LeafEase following a clinical assessment. You do not need a GP referral to get started.
Important: Medical cannabis for ADHD is not a first-line treatment. You will need a confirmed diagnosis and evidence that at least two conventional treatments have been trialled without adequate benefit.²
Medical cannabis may support ADHD symptom management by interacting with the body’s endocannabinoid system (ECS), which plays a role in regulating attention, impulse control, mood, and sleep. Cannabinoids like THC and CBD may help reduce hyperactivity, improve focus, and support emotional regulation. In the UK, medical cannabis for ADHD is prescribed and monitored by specialist clinicians to ensure safety and effectiveness.
Research into cannabis for ADHD in the UK is still developing, but existing data shows encouraging results for patients who have not responded to standard care.
Shannon, S. et al. (2019). Cannabidiol in Anxiety and Sleep: A Large Case Series. The Permanente Journal, 23:18–041.
UK Patient Survey (2025): In one of the largest studies of British medical cannabis patients, 84% reported their treatment was extremely or very effective at managing their symptoms. ⁵
This is one of the most common questions our patients ask.
The key differences are:
CBD oil is an over-the-counter food supplement containing cannabidiol (CBD) only. It is not regulated as a medicine, and its contents and concentration are not subject to the same quality controls as prescription medicines. It is not the same as a medical cannabis prescription.
Medical cannabis is a prescribed, regulated medicine dispensed under a specialist’s direct clinical supervision. It may contain both THC and CBD in clinically determined ratios, and is typically significantly more potent than CBD supplements. It is only available via a valid prescription from a licensed specialist clinic.
For patients with moderate-to-severe anxiety who have not responded adequately to conventional treatments or over-the-counter CBD, prescribed medical cannabis is a clinically distinct and more carefully managed therapeutic option.
A 2019 case series found that CBD reduced anxiety scores in 79% of patients within the first month of treatment, with effects maintained at three months.
Your initial consultation is with a GMC-registered specialist clinician who will review your medical history, previous treatments, and current symptoms. Consultations are conducted online at a time that suits you.
If medical cannabis is appropriate for you, your clinician will determine the right formulation and starting dose. They will explain how to use your medication safely and what to expect.
Your prescription is dispatched discreetly to your home address in clearly labelled original packaging with your prescription details attached.
LeafEase provides regular follow-up appointments to review how you are responding to treatment. Your prescription can be adjusted as needed.
Like any treatment, medical cannabis for ADHD may cause side effects in some individuals. These effects are typically mild and can vary depending on dosage, treatment type, and individual tolerance.
Possible side effects may include:
Specialist doctors carefully monitor treatment to ensure that medications are used safely and appropriately.
As a medical cannabis patient in the UK,
You have specific legal rights that are important to know:
You can use your prescribed medication, typically via a dry herb vaporiser, in public spaces such as parks, streets, and open areas. In private venues, staff may ask you to use a designated area. For large events, contact the venue in advance.
You are legally entitled to take your medication at work as directed by your doctor. Speak to your employer in advance if your role involves driving, operating machinery, or if your contract references controlled substances.
You must not drive if impaired. If your prescription contains THC, you may test above the legal roadside limit — but you can use the medical defence under Section 5A(3) of the Road Traffic Act 1988 if you are not impaired and are taking your medication as prescribed.
You are legally permitted to use your prescription medication in your rented home. This is not affected by clauses prohibiting smoking.
Contact the UK embassy for your destination country well in advance of travel. Bring your prescription, prescription-labelled medication tub, and personal ID. Request a travel letter from your clinician.
Yes. At LeafEase, you do not need a GP referral to book a specialist consultation. You can complete a free eligibility check online and, if you are eligible, proceed directly to a video appointment with one of our clinicians.
Stimulant medications like methylphenidate work by increasing dopamine activity in the brain. Medical cannabis interacts with the endocannabinoid system and may support attention, mood, and sleep through a different mechanism. It is typically considered where stimulants have not worked or have caused intolerable side effects, and is always prescribed under specialist supervision.
Response to treatment varies from person to person. Some patients report improvements in focus, impulsivity, and sleep, while others may not respond as well. This is why all prescriptions at LeafEase are started at a low dose and monitored closely, with regular follow-up appointments to review your progress and adjust treatment as needed.
Yes. A confirmed diagnosis is a clinical requirement before a prescription can be considered. If you have been assessed privately or through the NHS and have supporting documentation, your clinician will review this as part of your consultation.
If you have tried conventional ADHD treatments without success, medical cannabis for ADHD in the UK may be worth exploring.
Find out if medical cannabis may be right for you — no GP referral needed.
1. NHS Digital. MI ADHD: May 2025. digital.nhs.uk
2. UK Home Office (2018). Rescheduling of cannabis-based products for medicinal use in humans. gov.uk
3. Ittiphakorn P, et al. (2023). UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention-deficit/hyperactivity disorder. Neuropsychopharmacology Reports. doi:10.1002/npr2.12400
4. Cooper RE, et al. (2017). Evaluation of the effects of cannabinoids on ADHD symptoms. European Neuropsychopharmacology. doi:10.1016/j.euroneuro.2017.05.005
5. UK Medical Cannabis Patient Survey (2025). Patient-reported outcomes across British medical cannabis patients.
Important notice: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified clinician before changing your treatment.
Regulatory note: Medical cannabis is a Schedule 2 controlled drug in the UK, prescribable only by a GMC-registered specialist. LeafEase is fully CQC-registered.
